Published in Front Immunol on September 12, 2013
Large scale characterization of the LC13 TCR and HLA-B8 structural landscape in reaction to 172 altered peptide ligands: a molecular dynamics simulation study. PLoS Comput Biol (2014) 0.83
Changing the peptide specificity of a human T-cell receptor by directed evolution. Nat Commun (2014) 0.80
Identifying Individual T Cell Receptors of Optimal Avidity for Tumor Antigens. Front Immunol (2015) 0.80
Immune response to cancer therapy: mounting an effective antitumor response and mechanisms of resistance. Trends Cancer (2015) 0.79
A generalized framework for computational design and mutational scanning of T-cell receptor binding interfaces. Protein Eng Des Sel (2016) 0.78
An old Twist in HLA-A: CDR3α Hook up at an R65-joint. Front Immunol (2015) 0.78
DynaDom: structure-based prediction of T cell receptor inter-domain and T cell receptor-peptide-MHC (class I) association angles. BMC Struct Biol (2017) 0.75
Using Global Analysis to Extend the Accuracy and Precision of Binding Measurements with T cell Receptors and Their Peptide/MHC Ligands. Front Mol Biosci (2017) 0.75
Comparative protein modelling by satisfaction of spatial restraints. J Mol Biol (1993) 64.61
All-atom empirical potential for molecular modeling and dynamics studies of proteins. J Phys Chem B (1998) 54.00
CHARMM: the biomolecular simulation program. J Comput Chem (2009) 27.71
Comparative protein structure modeling of genes and genomes. Annu Rev Biophys Biomol Struct (2000) 17.81
Calculating structures and free energies of complex molecules: combining molecular mechanics and continuum models. Acc Chem Res (2000) 10.78
Adoptive cell transfer: a clinical path to effective cancer immunotherapy. Nat Rev Cancer (2008) 9.82
Modeling of loops in protein structures. Protein Sci (2000) 9.68
Gene therapy with human and mouse T-cell receptors mediates cancer regression and targets normal tissues expressing cognate antigen. Blood (2009) 9.24
Comparative protein structure modeling using Modeller. Curr Protoc Bioinformatics (2006) 8.72
How TCRs bind MHCs, peptides, and coreceptors. Annu Rev Immunol (2006) 7.57
Serial triggering of many T-cell receptors by a few peptide-MHC complexes. Nature (1995) 7.40
Adoptive immunotherapy for cancer: harnessing the T cell response. Nat Rev Immunol (2012) 7.39
Comprehensive assessment of T-cell receptor beta-chain diversity in alphabeta T cells. Blood (2009) 7.00
A direct estimate of the human alphabeta T cell receptor diversity. Science (1999) 6.85
A testicular antigen aberrantly expressed in human cancers detected by autologous antibody screening. Proc Natl Acad Sci U S A (1997) 6.67
Structure of the complex between human T-cell receptor, viral peptide and HLA-A2. Nature (1996) 6.20
The RCSB Protein Data Bank: new resources for research and education. Nucleic Acids Res (2012) 5.73
Ligand recognition by alpha beta T cell receptors. Annu Rev Immunol (1998) 5.11
Kinetic proofreading in T-cell receptor signal transduction. Proc Natl Acad Sci U S A (1995) 5.01
Free energy reconstruction from nonequilibrium single-molecule pulling experiments. Proc Natl Acad Sci U S A (2001) 4.56
Calculation of the total electrostatic energy of a macromolecular system: solvation energies, binding energies, and conformational analysis. Proteins (1988) 4.37
Insights into protein-protein binding by binding free energy calculation and free energy decomposition for the Ras-Raf and Ras-RalGDS complexes. J Mol Biol (2003) 3.89
Calculating potentials of mean force from steered molecular dynamics simulations. J Chem Phys (2004) 3.81
Structural basis of plasticity in T cell receptor recognition of a self peptide-MHC antigen. Science (1998) 3.64
The antigenic identity of peptide-MHC complexes: a comparison of the conformations of five viral peptides presented by HLA-A2. Cell (1993) 3.44
Ex vivo staining of metastatic lymph nodes by class I major histocompatibility complex tetramers reveals high numbers of antigen-experienced tumor-specific cytolytic T lymphocytes. J Exp Med (1998) 3.04
Steered molecular dynamics investigations of protein function. J Mol Graph Model (2001) 3.04
Quantitative analysis of the contribution of TCR/pepMHC affinity and CD8 to T cell activation. Immunity (2003) 3.04
Directed evolution of human T-cell receptors with picomolar affinities by phage display. Nat Biotechnol (2005) 2.97
Integrated NY-ESO-1 antibody and CD8+ T-cell responses correlate with clinical benefit in advanced melanoma patients treated with ipilimumab. Proc Natl Acad Sci U S A (2011) 2.90
How T cells 'see' antigen. Nat Immunol (2005) 2.87
Four A6-TCR/peptide/HLA-A2 structures that generate very different T cell signals are nearly identical. Immunity (1999) 2.86
Efficient T cell activation requires an optimal dwell-time of interaction between the TCR and the pMHC complex. Nat Immunol (2001) 2.83
Dependence of T cell antigen recognition on T cell receptor-peptide MHC confinement time. Immunity (2010) 2.82
Stable, soluble T-cell receptor molecules for crystallization and therapeutics. Protein Eng (2003) 2.75
Hidden thermodynamics of mutant proteins: a molecular dynamics analysis. Science (1989) 2.72
Energetics of charge-charge interactions in proteins. Proteins (1988) 2.56
Two-step binding mechanism for T-cell receptor recognition of peptide MHC. Nature (2002) 2.45
The contribution of vibrational entropy to molecular association. The dimerization of insulin. J Mol Biol (1994) 2.45
Active site dynamics in protein molecules: a stochastic boundary molecular-dynamics approach. Biopolymers (1985) 2.43
Crystal structure of the beta chain of a T cell antigen receptor. Science (1995) 2.37
Comparison of efficiency and bias of free energies computed by exponential averaging, the Bennett acceptance ratio, and thermodynamic integration. J Chem Phys (2005) 2.31
Structural and kinetic basis for heightened immunogenicity of T cell vaccines. J Exp Med (2005) 2.22
Fidelity of T cell activation through multistep T cell receptor zeta phosphorylation. Science (1998) 2.13
Human TCR-binding affinity is governed by MHC class restriction. J Immunol (2007) 2.02
IMGT/3Dstructure-DB and IMGT/DomainGapAlign: a database and a tool for immunoglobulins or antibodies, T cell receptors, MHC, IgSF and MhcSF. Nucleic Acids Res (2009) 1.94
In vitro evolution of a T cell receptor with high affinity for peptide/MHC. Proc Natl Acad Sci U S A (2000) 1.92
The kinetics of protein-protein recognition. Proteins (1997) 1.91
The fidelity, occasional promiscuity, and versatility of T cell receptor recognition. Immunity (2008) 1.89
T-cell receptor binding affinities and kinetics: impact on T-cell activity and specificity. Immunology (2009) 1.85
High-affinity TCRs generated by phage display provide CD4+ T cells with the ability to recognize and kill tumor cell lines. J Immunol (2007) 1.85
FACTS: Fast analytical continuum treatment of solvation. J Comput Chem (2008) 1.79
Basic ingredients of free energy calculations: a review. J Comput Chem (2010) 1.60
Hard wiring of T cell receptor specificity for the major histocompatibility complex is underpinned by TCR adaptability. Proc Natl Acad Sci U S A (2010) 1.60
Crystal structure of an H-2Kb-ovalbumin peptide complex reveals the interplay of primary and secondary anchor positions in the major histocompatibility complex binding groove. Proc Natl Acad Sci U S A (1995) 1.59
Computational design of affinity and specificity at protein-protein interfaces. Curr Opin Struct Biol (2009) 1.59
How the T cell receptor sees antigen--a structural view. Cell (2005) 1.58
Two different T cell receptors use different thermodynamic strategies to recognize the same peptide/MHC ligand. J Mol Biol (2005) 1.55
CD8+ T cell activation is governed by TCR-peptide/MHC affinity, not dissociation rate. J Immunol (2007) 1.54
A functional hot spot for antigen recognition in a superagonist TCR/MHC complex. Immunity (2000) 1.54
Conversion of a T cell antagonist into an agonist by repairing a defect in the TCR/peptide/MHC interface: implications for TCR signaling. Immunity (2000) 1.48
A general method for facilitating heterodimeric pairing between two proteins: application to expression of alpha and beta T-cell receptor extracellular segments. Proc Natl Acad Sci U S A (1994) 1.44
Cancer-testis antigens are commonly expressed in multiple myeloma and induce systemic immunity following allogeneic stem cell transplantation. Blood (2006) 1.41
Comparison of free energy methods for molecular systems. J Chem Phys (2006) 1.34
Thermodynamics of T-cell receptor-peptide/MHC interactions: progress and opportunities. J Mol Recognit (2008) 1.34
Evidence for a TCR affinity threshold delimiting maximal CD8 T cell function. J Immunol (2010) 1.33
Structural prediction of peptides bound to MHC class I. J Mol Biol (2005) 1.33
Directed evolution of human T cell receptor CDR2 residues by phage display dramatically enhances affinity for cognate peptide-MHC without increasing apparent cross-reactivity. Protein Sci (2006) 1.31
New perspectives for large-scale repertoire analysis of immune receptors. Mol Immunol (2008) 1.29
Study of the insulin dimerization: binding free energy calculations and per-residue free energy decomposition. Proteins (2005) 1.27
Theoretical and computational protein design. Annu Rev Phys Chem (2011) 1.26
Comparison between computational alanine scanning and per-residue binding free energy decomposition for protein-protein association using MM-GBSA: application to the TCR-p-MHC complex. Proteins (2007) 1.25
Characterization of T cell receptors engineered for high affinity against toxic shock syndrome toxin-1. J Mol Biol (2005) 1.25
High-affinity, peptide-specific T cell receptors can be generated by mutations in CDR1, CDR2 or CDR3. J Mol Biol (2004) 1.21
Crystal structure of the V alpha domain of a T cell antigen receptor. Science (1995) 1.21
The structural basis of αβ T-lineage immune recognition: TCR docking topologies, mechanotransduction, and co-receptor function. Immunol Rev (2012) 1.20
Crystal structures of high affinity human T-cell receptors bound to peptide major histocompatibility complex reveal native diagonal binding geometry. Protein Eng Des Sel (2007) 1.19
Structure-based design of a T-cell receptor leads to nearly 100-fold improvement in binding affinity for pepMHC. Proteins (2009) 1.16
Interplay between T cell receptor binding kinetics and the level of cognate peptide presented by major histocompatibility complexes governs CD8+ T cell responsiveness. J Biol Chem (2012) 1.16
A structural voyage toward an understanding of the MHC-I-restricted immune response: lessons learned and much to be learned. Immunol Rev (2012) 1.14
Vaccination with a Melan-A peptide selects an oligoclonal T cell population with increased functional avidity and tumor reactivity. J Immunol (2002) 1.11
High affinity T cell receptors from yeast display libraries block T cell activation by superantigens. J Mol Biol (2001) 1.10
Distinct structural TCR repertoires in naturally occurring versus vaccine-induced CD8+ T-cell responses to the tumor-specific antigen NY-ESO-1. J Immunother (2005) 1.10
Display, engineering, and applications of antigen-specific T cell receptors. Biomol Eng (2007) 1.08
Prevalent role of TCR alpha-chain in the selection of the preimmune repertoire specific for a human tumor-associated self-antigen. J Immunol (2003) 1.07
Solution mapping of T cell receptor docking footprints on peptide-MHC. Proc Natl Acad Sci U S A (2007) 1.06
Binding free energy differences in a TCR-peptide-MHC complex induced by a peptide mutation: a simulation analysis. J Mol Biol (2002) 1.05
Antigen potency and maximal efficacy reveal a mechanism of efficient T cell activation. Sci Signal (2011) 1.04
Protein-protein recognition and interaction hot spots in an antigen-antibody complex: free energy decomposition identifies "efficient amino acids". Proteins (2007) 1.03
Unraveling a hotspot for TCR recognition on HLA-A2: evidence against the existence of peptide-independent TCR binding determinants. J Mol Biol (2005) 1.03
Development of adoptive cell therapy for cancer: a clinical perspective. Hum Gene Ther (2010) 1.03
MM-GBSA binding free energy decomposition and T cell receptor engineering. J Mol Recognit (2010) 1.01
Protein-protein interaction investigated by steered molecular dynamics: the TCR-pMHC complex. Biophys J (2008) 1.00
Engineering higher affinity T cell receptors using a T cell display system. J Immunol Methods (2008) 1.00
Canonical structures for the hypervariable regions of T cell alphabeta receptors. J Mol Biol (2000) 1.00
Engineering the binding properties of the T cell receptor:peptide:MHC ternary complex that governs T cell activity. Mol Immunol (2009) 0.99
Recent advances in computational protein design. Curr Opin Struct Biol (2011) 0.97
A panel of cancer-testis genes exhibiting broad-spectrum expression in haematological malignancies. Cancer Immun (2010) 0.97
Modeling of the TCR-MHC-peptide complex. J Mol Biol (2000) 0.95
The Serial Engagement Model 17 Years After: From TCR Triggering to Immunotherapy. Front Immunol (2012) 0.94
Retrospective study of 1000 deaths from injury in England and Wales. Br Med J (Clin Res Ed) (1988) 10.18
Accuracy of hospital activity analysis operation codes. Br Med J (Clin Res Ed) (1982) 6.14
Surgical audit: one year's experience in a teaching hospital. Br Med J (1976) 3.27
The Old Bailey bomb explosion. Lancet (1973) 3.01
Calcium signals recorded from cut frog twitch fibers containing antipyrylazo III. J Gen Physiol (1987) 2.65
Elastic bending and active tilting of myosin heads during muscle contraction. Nature (1998) 2.64
Dynamic measurement of myosin light-chain-domain tilt and twist in muscle contraction. Nature (1999) 2.42
Intrinsic optical and passive electrical properties of cut frog twitch fibers. J Gen Physiol (1987) 2.35
The stiffness of skeletal muscle in isometric contraction and rigor: the fraction of myosin heads bound to actin. Biophys J (1998) 2.12
Comparison of arsenazo III optical signals in intact and cut frog twitch fibers. J Gen Physiol (1987) 2.05
Elastic distortion of myosin heads and repriming of the working stroke in muscle. Nature (1995) 1.83
Crystal structures of two closely related but antigenically distinct HLA-A2/melanocyte-melanoma tumor-antigen peptide complexes. J Immunol (2001) 1.77
Calcium signals recorded from cut frog twitch fibers containing tetramethylmurexide. J Gen Physiol (1987) 1.77
Home parenteral nutrition in the United Kingdom and Ireland. Lancet (1986) 1.77
Fluorescence polarization transients from rhodamine isomers on the myosin regulatory light chain in skeletal muscle fibers. Biophys J (1998) 1.75
Relation between sequence and structure of HIV-1 protease inhibitor complexes: a model system for the analysis of protein flexibility. J Mol Biol (2002) 1.72
Human immune response to a plague vaccine comprising recombinant F1 and V antigens. Infect Immun (2005) 1.69
High-energy phosphate metabolism and energy liberation associated with rapid shortening in frog skeletal muscle. J Physiol (1981) 1.60
Cardiac complications of total parenteral nutrition: the role of two-dimensional echocardiography in diagnosis. Ann R Coll Surg Engl (1989) 1.58
Interference fine structure and sarcomere length dependence of the axial x-ray pattern from active single muscle fibers. Proc Natl Acad Sci U S A (2000) 1.50
Care of emergencies in the United Kingdom. Br Med J (Clin Res Ed) (1981) 1.50
Fluorescent probes of the orientation of myosin regulatory light chains in relaxed, rigor, and contracting muscle. Biophys J (1996) 1.42
Orientation changes in myosin regulatory light chains following photorelease of ATP in skinned muscle fibers. Biophys J (1996) 1.32
Model-independent analysis of the orientation of fluorescent probes with restricted mobility in muscle fibers. Biophys J (1999) 1.23
Changes in conformation of myosin heads during the development of isometric contraction and rapid shortening in single frog muscle fibres. J Physiol (1999) 1.19
First-line temozolomide combined with bevacizumab in metastatic melanoma: a multicentre phase II trial (SAKK 50/07). Ann Oncol (2011) 1.16
Orientation changes of fluorescent probes at five sites on the myosin regulatory light chain during contraction of single skeletal muscle fibres. J Mol Biol (1998) 1.16
Steady-state fluorescence polarization studies of the orientation of myosin regulatory light chains in single skeletal muscle fibers using pure isomers of iodoacetamidotetramethylrhodamine. Biophys J (1998) 1.14
The structural basis of the increase in isometric force production with temperature in frog skeletal muscle. J Physiol (2005) 1.10
Intraperitoneal low-pressure suction drainage following splenectomy. Br J Surg (1985) 1.09
Rebound tenderness test. Br J Surg (1991) 1.09
Structural changes in the myosin filament and cross-bridges during active force development in single intact frog muscle fibres: stiffness and X-ray diffraction measurements. J Physiol (2006) 1.07
Advanced trauma life support courses. J R Soc Med (1990) 1.06
Return to work following ileostomy. Br J Surg (1984) 1.06
Intensive investigation in management of Hodgkin's disease. Br Med J (1976) 1.04
Failure of delayed hypersensitivity skin testing to predict postoperative sepsis and mortality. Br Med J (Clin Res Ed) (1982) 1.03
Myosin crossbridge orientation in demembranated muscle fibres studied by birefringence and X-ray diffraction measurements. J Mol Biol (1989) 1.03
Changes in the x-ray diffraction pattern from single, intact muscle fibers produced by rapid shortening and stretch. Biophys J (1995) 1.03
Home parenteral nutrition in adults: a multicentre survey in Europe. Clin Nutr (1989) 1.01
Somatostatin and octreotide in the prevention of postoperative pancreatic complications and the treatment of enterocutaneous pancreatic fistulas: a systematic review of randomized controlled trials. Br J Surg (2001) 1.01
MM-GBSA binding free energy decomposition and T cell receptor engineering. J Mol Recognit (2010) 1.01
Appraisal of percutaneous tracheostomy. Br J Surg (1992) 1.01
Effects of sarcomere length and temperature on the rate of ATP utilisation by rabbit psoas muscle fibres. J Physiol (2001) 0.98
The conformation of myosin head domains in rigor muscle determined by X-ray interference. Biophys J (2003) 0.97
Muscle. Give in the filaments. Nature (1995) 0.97
A safe and effective disposable low pressure suction drain. Br J Surg (1979) 0.96
The skeletal manifestations of the congenital disorders of glycosylation. Clin Genet (2008) 0.96
The dependence on extent of shortening of the extra energy liberated by rapidly shortening frog skeletal muscle. J Physiol (1981) 0.96
Protection of the skin around intestinal fistulas. Br J Surg (1977) 0.95
Effect of active shortening on the rate of ATP utilisation by rabbit psoas muscle fibres. J Physiol (2001) 0.94
Structural changes in myosin motors and filaments during relaxation of skeletal muscle. J Physiol (2009) 0.94
Colo-broncho-cutaneous fistula complicating traumatic diaphragmatic rupture. J R Soc Med (2001) 0.93
Protein-ligand binding free energy estimation using molecular mechanics and continuum electrostatics. Application to HIV-1 protease inhibitors. J Comput Aided Mol Des (2003) 0.90
The heat produced by frog muscle in a series of contractions with shortening. J Physiol (1979) 0.89
The general surgeon. Br Med J (Clin Res Ed) (1986) 0.88
Three years' experience with an intestinal failure unit. Ann R Coll Surg Engl (1985) 0.88
Family perspectives on deceased organ donation: thematic synthesis of qualitative studies. Am J Transplant (2014) 0.87
The energy liberation of frog skeletal muscle in tetanic contractions containing two periods of shortening. J Physiol (1981) 0.85
A birefringence study of changes in myosin orientation during relaxation of skinned muscle fibers induced by photolytic ATP release. Biophys J (1994) 0.84
T cell recognition of hapten. Anatomy of T cell receptor binding of a H-2kd-associated photoreactive peptide derivative. J Biol Chem (1999) 0.84
Intestinal failure after surgery for complicated radiation enteritis. Ann R Coll Surg Engl (2000) 0.84
Time-lapse FRET microscopy using fluorescence anisotropy. J Microsc (2010) 0.84
Rate of actomyosin ATP hydrolysis diminishes during isometric contraction. Adv Exp Med Biol (2003) 0.83
Motor proteins. Biomechanics goes quantum. Nature (1991) 0.83
Local and surgical management of enterocutaneous fistulas. Br J Surg (1977) 0.83
A single mutation in enzyme I of the sugar phosphotransferase system confers penicillin tolerance to Streptococcus gordonii. Antimicrob Agents Chemother (2009) 0.83
Data acquisition, data storage, and data presentation in a modern genetics laboratory. Rev Immunogenet (2000) 0.83
The role of surgery in the management of Hodgkin's disease. Br J Surg (1975) 0.82
Mechanics of myosin function in white muscle fibres of the dogfish, Scyliorhinus canicula. J Physiol (2012) 0.82
Ethical problems associated with the treatment of intestinal failure. Aust N Z J Surg (1986) 0.82
Transients of fluorescence polarization in skeletal muscle fibers labeled with rhodamine on the regulatory light chain. Biophys J (1995) 0.82
Dramatic influence of V beta gene polymorphism on an antigen-specific CD8+ T cell response in vivo. J Immunol (1999) 0.81
Manometric asymmetry in the anal canal in controls and patients with fecal incontinence. Dis Colon Rectum (1995) 0.81
The effect of shortening on energy liberation and high energy phosphate hydrolysis in frog skeletal muscle. Adv Exp Med Biol (1984) 0.80
External intestinal fistulas: nursing care and surgical procedures. Clin Gastroenterol (1982) 0.80
Therapeutic value of octreotide for patients with severe dumping syndrome--a review of randomised controlled trials. Postgrad Med J (2001) 0.80
Assessment and management of external fistulas in Crohn's disease. Br J Surg (1983) 0.80
A complex deletion-inversion-deletion event results in a chimeric IL1RAPL1-dystrophin transcript and a contiguous gene deletion syndrome. J Med Genet (2003) 0.80
Delayed hypersensitivity skin testing does not influence the management of surgical patients. Ann Surg (1982) 0.80
Primary skeletal dysplasia as a major manifesting feature in an infant with congenital disorder of glycosylation type Ia. Am J Med Genet A (2008) 0.80
Dependence of shortening heat on distance shortened in frog skeletal muscle [proceedings]. J Physiol (1979) 0.79
TNF alpha and IL-6 involvement in surgical trauma. II. In vitro cytokine production. Rev Med Chir Soc Med Nat Iasi (2002) 0.79
Urinary 3-methylhistidine:creatinine ratio in patients on long-term parenteral nutrition. JPEN J Parenter Enteral Nutr (1980) 0.78
The variation in shortening heat with sarcomere length in frog muscle. J Physiol (1983) 0.78
Weak and strong crossbridges. Nature (1985) 0.78
The changing use of palliative chemotherapy for recurrent esophagogastric cancer: a single center retrospective 15-year review. J Gastrointest Cancer (2009) 0.78
Contemporary surgery. Splenectomy. Br J Hosp Med (1978) 0.78
Maturation of muscle properties and its hormonal control in an adult insect. J Exp Biol (2001) 0.78
Comparison between tension transients during isometric contraction and in rigor in isolated fibers from frog skeletal muscle. Biophys J (1995) 0.77
Motor proteins. Another step ahead for myosin. Nature (1999) 0.76
Small bowel fistulas. World J Surg (1985) 0.76
Opiate and sedative dependence predicts a poor outcome for patients receiving home parenteral nutrition. JPEN J Parenter Enteral Nutr (1998) 0.76
Investigation of anal function in patients with systemic sclerosis. Ann Rheum Dis (1996) 0.76
Spread of steroid-containing foam after intrarectal administration. Br Med J (1979) 0.75
Intravenous nutrition: the materials available. Proc R Soc Med (1973) 0.75
ABC of nutrition. Enteral and parenteral nutrition. Br Med J (Clin Res Ed) (1985) 0.75
The investigation of abdominal trauma. Arch Emerg Med (1990) 0.75
Current studies in surgical shock. Proc R Soc Med (1972) 0.75